Literature DB >> 7488863

Delayed intestinal absorption of levothyroxine.

S Benvenga1, L Bartolone, S Squadrito, F Lo Giudice, F Trimarchi.   

Abstract

We report four female patients with nodular goiter (in two of the four due to Hashimoto's thyroiditis) and one male patient with frank hypothyroidism due to Hashimoto's thyroiditis in whom TSH-suppressive or replacement L-T4 therapy failed to suppress or, respectively, normalize serum TSH. As is typical in our country, our patients took L-T4 15-20 min before a light breakfast. Gastrointestinal or other diseases and drugs known to interfere with the intestinal absorption of L-T4 were not the cause of this failure. The gastrointestinal absorption test of L-T4 (1000 micrograms) was performed in four patients; in three patients it revealed peculiar abnormalities in that (i) the absorption peak was > 70% but occurred at 4 hr vs an average of 2 hr in 12 euthyroid controls (EC) and 3 hr in the 10 primary hypothyroid controls (HC); (ii) 50% of the maximal absorption occurred at 110 min vs 45 min in EC and 50 min in HC; (iii) the maximal increment in T4 absorption was between 90 and 120 min (+111%) vs between 30 and 60 min in EC (+312%) and HC (+354%). In sum, only the first part of the absorption curve of T4 was shifted to the right (in three of the four women) and this shift was more pronounced and extended to the second part of the curve in the fourth patient; in this last patient absorption peak was 44% at 180 min. Based on these results, we obtained full suppression or normalization of TSH by postponing breakfast for at least 60 min after T4 ingestion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488863     DOI: 10.1089/thy.1995.5.249

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  53 in total

1.  Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

Authors:  Ileana Gabriela Sanchez Rubio; Ana Luiza Galrão; Marco Aurelio Santo; Antonio Carlos Zanini; Geraldo Medeiros-Neto
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

2.  Treatment-refractory hypothyroidism.

Authors:  Abdulaziz Ramadhan; Michael Tamilia
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

3.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

Review 4.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

5.  Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism.

Authors:  Nancy Van Wilder; Bert Bravenboer; Sarah Herremans; Nathalie Vanderbruggen; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2016-11-24

6.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

7.  A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.

Authors:  N Yannovits; E Zintzaras; A Pouli; G Koukoulis; S Lyberi; E Savari; S Potamianos; F Triposkiadis; I Stefanidis; E Zartaloudis; A Benakis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

8.  Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.

Authors:  Celestino Pio Lombardi; Raffaella Bocale; Angelina Barini; Antonella Barini; Annamaria D'Amore; Mauro Boscherini; Rocco Bellantone
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

9.  [Bioequivalence of a combination of levothyroxine and iodine in comparison with levothyroxine only. A controlled double-blind study of bioavailability].

Authors:  G Förster; C Hansen; F Mörsch; K al-Hakim; J Beyer; G Kahaly
Journal:  Med Klin (Munich)       Date:  1998-07-15

10.  Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.

Authors:  Valeria Guglielmi; Alfonso Bellia; Elisa Bianchini; Gerardo Medea; Iacopo Cricelli; Paolo Sbraccia; Davide Lauro; Claudio Cricelli; Francesco Lapi
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.